Parameters | Findings | Findings | Remarks
Anti Neutrophil Cytoplasmic Antibodies (IFA) | Anti Neutrophil Cytoplasmic Antibodies (IFA) | Anti Neutrophil Cytoplasmic Antibodies (IFA) | Anti Neutrophil Cytoplasmic Antibodies (IFA)
c-ANCA | c-ANCA | 1.37 U/ml | Negative
p-ANCA | p-ANCA | - | Negative
Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel | Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel | Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel | Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel
PDGFRA rearrangement (4q12) | PDGFRA rearrangement (4q12) | 0 | Negative
PDGFRB rearrangement (5q33) | PDGFRB rearrangement (5q33) | 0 | Negative
FGFR1 rearrangement (8p11.22-11.23) | FGFR1 rearrangement (8p11.22-11.23) | 0 | Negative
CBFB rearrangement (Inv 16) | CBFB rearrangement (Inv 16) | 0 | Negative
Bone marrow examination | Bone marrow examination | Bone marrow examination | Bone marrow examination
Cellularity | Cellularity | Hypercellular |
Erythroid series | Erythroid series | Present with normoblastic maturation |
Myeloid series | Myeloid series | Increased with progressive maturation up to neutrophils. Markedly increased eosinophils and precursors were noted, which show dysplasia in the form of abnormal segmentation and irregular distribution of granules. | Myeloid hyperplasia